Vialize Use for the Reduction of Vascular Groin Incisional Dehiscence and Infection

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 23, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Vascular Diseases
Interventions
OTHER

Vialize

Any patients undergoing surgeries involving a groin incision (e.g., femoropopliteal bypass, aortofemoral bypass, loop thigh graft, femoral exposure for delivery of device) will receive Vialize subcutaneously.

Trial Locations (1)

32608

UF Health Heart & Vascular Hospital, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER

NCT06032949 - Vialize Use for the Reduction of Vascular Groin Incisional Dehiscence and Infection | Biotech Hunter | Biotech Hunter